SEC Form D private-offering filing

BioRestorative Therapies, Inc.

Name: BioRestorative Therapies, Inc. - new SEC Form D private-offering filing, Melville, NY
Published: 2025-10-09

A new SEC Form D private-offering notice from Melville, NY, a $1,398,628 filer-stated offering target in Biotech. The source filing is one click away.

BioRestorative Therapies, Inc. site↗ Verified via SEC Form D

Publicly traded biotechnology company developing autologous stem cell therapies, including BRTX-100 for lumbar disc disease and ThermoStem for metabolic disorders

Filed 2025-10-09Filed to raise $1,398,628First money in 2025-10-08Raised so far $1,398,628HQ (as filed) Melville, NYSector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified biorestorative.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.